Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.645 USD | -2.40% | -7.84% | -21.28% |
05-02 | Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos | MT |
05-01 | Malin Corp investee signs agreement with Astellas Pharma | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.28% | 256M | |
+3.91% | 109B | |
+10.87% | 105B | |
0.00% | 22.25B | |
-13.14% | 22.09B | |
-8.49% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q2 Revenue $20M